September 24, 2024 14:35 GMT
HEALTHCARE: McKesson (MCK: A3/BBB+): 23% fall from high
HEALTHCARE
- MCK is down again today following Baird's analyst cut to Neutral
- So far, the fall is an equity story - the stock was highly valued
- The stock price is now 23% below the high of early August
- OnSep 5th, the company lowered its guidance for 2Q25 to EPS $6.7-$7
- Guidance for the full year was still EPS $31.75 - $32.55
- Results are on 6th November
60 words